Clinical trials in Homburg – page 18

212 clinical trials in Homburg, Germany across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in GermanyKlinischeStudien.de

Homburg at a glance

212

clinical trials

Research sites2

Quick filters

212 trials in Homburg

Open in trial search

Neurotrophic keratopathy

Not recruiting

Study on the Safety and Effectiveness of RGN-259 Eye Drops for Patients with Neurotrophic Keratopathy

Investigational

Study on the Safety and Effectiveness of RGN-259 Eye Drops for Patients with Neurotrophic Keratopathy

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Timbetasin Acetate
Sponsor:Regentree LLC

Contact Research Centre

Diabetic neuropathy+1

Not recruiting

Study on the Effectiveness and Safety of AP707, Amitriptyline, and Capsaicin for Patients with Chronic Pain from Diabetic Neuropathy

Registered drug

Study on the Effectiveness and Safety of AP707, Amitriptyline, and Capsaicin for Patients with Chronic Pain from Diabetic Neuropathy

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Adezunap
Sponsor:Apurano Pharmaceuticals GmbH

Contact Research Centre

Dementia Alzheimer's type

Not recruiting

Study on the Effects of ABBV-552 in Patients Aged 50-90 with Mild Alzheimer's Disease

Investigational

Study on the Effects of ABBV-552 in Patients Aged 50-90 with Mild Alzheimer's Disease

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:(4R)-1-[(5-Chloro-1H-1,2,4-Triazol-1-Yl)Methyl]-4-(3,4,5-Trifluorophenyl)-2-Pyrrolidinone
Sponsor:AbbVie Deutschland GmbH & Co. KG

Contact Research Centre

Corneal dystrophy

Not recruiting

Study on the Safety and Effectiveness of Ripasudil Eye Drops for Patients with Fuchs Dystrophy After Cataract Surgery

Investigational

Study on the Safety and Effectiveness of Ripasudil Eye Drops for Patients with Fuchs Dystrophy After Cataract Surgery

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Ripasudil
Sponsor:Kowa Research Institute Inc.

Contact Research Centre

Germ cell cancer

Not recruiting

Study Comparing Carboplatin and Cisplatin for Patients with Extracranial Malignant Germ Cell Tumors

Registered drugNo placebo

Study Comparing Carboplatin and Cisplatin for Patients with Extracranial Malignant Germ Cell Tumors

Registered drugNo placebo

Germany

Participants:0–17 years · 18–64 years
Substances:Carboplatin
Sponsor:Rheinische Friedrich-Wilhelms-Universitaet Bonn

Contact Research Centre

Cervix carcinoma

Not recruiting

Study on Atezolizumab, Bevacizumab, and Chemotherapy for Patients with Advanced Cervical Cancer

Registered drugNo placebo

Study on Atezolizumab, Bevacizumab, and Chemotherapy for Patients with Advanced Cervical Cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Atezolizumab
Sponsor:Fundacion Grupo Espanol De Investigacion En Cancer Ginecologico

Contact Research Centre

Acute lymphocytic leukaemia

Not recruiting

Study on Imatinib and Chemotherapy Combination for Children with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Registered drugNo placebo

Study on Imatinib and Chemotherapy Combination for Children with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Registered drugNo placebo

Germany

Participants:0–17 years · 18–64 years
Substances:Crisantaspase
Sponsor:Universita Degli Studi Di Milano Bicocca

Contact Research Centre

Mantle cell lymphoma stage II+2

Not recruiting

Study on Ibrutinib and Drug Combination for Patients with Generalized Mantle Cell Lymphoma

Registered drugNo placebo

Study on Ibrutinib and Drug Combination for Patients with Generalized Mantle Cell Lymphoma

Registered drugNo placebo

Germany

Participants:18–64 years
Substances:Ibrutinib
Sponsor:Klinikum der Universitaet Muenchen AöR

Contact Research Centre

Other cities in Germany

The busiest research cities in the country

All 518 cities in Germany

Clinical research in Homburg

What the registry says about research in the country

01 Hematologic Oncology

Innovative research focusing on lymphoma and leukemia treatments, including studies evaluating novel therapies for chronic lymphocytic leukemia and various types of B-cell lymphomas.

Mantle Cell Lymphoma
Diffuse Large B-cell Lymphoma
Chronic Lymphocytic Leukemia

Multiple trials exploring CAR-T cell therapies and targeted treatment combinations.

02 Breast Cancer Research

Comprehensive studies investigating treatments for various types of breast cancer, particularly focusing on hormone receptor-positive and HER2-positive disease.

Early-Stage Breast Cancer
Triple-Negative Breast Cancer
HER2-Positive Disease

Evaluating new combination therapies and targeted treatments for improved patient outcomes.

03 Cardiovascular Medicine

Studies addressing heart failure prevention and treatment, with innovative approaches to reducing cardiovascular risks.

Heart Failure Prevention
Pulmonary Arterial Hypertension

Testing novel drug combinations to improve cardiovascular outcomes and patient quality of life.

Back to Germany All countries